Multiple studies also illustrated EIF3D’s pivotal role in carcinogenesis through the regulation of translational initiation and oncogene expression [4, 9–12], suggesting the potential utility as both a novel biomarker and a target for cancer therapeutics. This evidence concerns the gene EIF3D and cancer.